Two new reports from the World Health Organization (WHO) suggest that the development of new treatments and tests for ...

These criteria ensure that the drug offers a genuine therapeutic difference, a requirement for its effectiveness against evolving AMR. Considering it can take 15 years and cost over $1 billion to ...

New research into antimicrobial peptides, small chains of amino acids able to damage bacterial cells, shows why some peptides are more effective at doing that and also why some cells are more ...

The World Health Organization (WHO) today released its latest reports on antibacterial agents in clinical and preclinical ...

CDC reports a major surge in NDM-producing carbapenem-resistant Enterobacterales infections that may defy most antibiotics.

A new study published in the journal of Infectious Disorders - Drug Targets revealed that Licorice extract gel has strong ...

ProteCoat™ is a non-toxic antimicrobial coating technology developed by Reactive Surfaces aimed at reducing healthcare-associated infections (HAIs) in hospitals and public spaces ...

The global infectious disease diagnostics market is set to witness a CAGR of ~7% in the next 5 years. Increasing prevalence ...

As a college kid working on developing a professional career, I think it's important to test and try out all different types of careers. This time I decided to see if I had what it takes to be an FBI ...

Big Pharma is vacating infectious diseases research to chase more lucrative segments like oncology and diabetes. This has left behind a gaping void. A set of Indian companies are diving in—Wockhardt, ...

The landscape of antibacterial therapies in India is evolving to address the antimicrobial resistance (AMR). Many research centres are exploring alternative antibacterial therapies. By adopting ...